This product is an ASHP Learning Center activity.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
These activities are designed for pharmacists who are interested in expanding their knowledge and skills in specialty pharmacy management of hepatitis.
Overview
The Specialty Pharmacy Certificate is self-guided, with online learning activities allowing learners to tailor their learning experience.
A learner will have completed the Specialty Pharmacy Fundamentals before beginning the Hepatitis Track.
The learner will then take a deep dive into their selected specialty focus with the Hepatitis Track. These topics include a hepatitis overview, hepatitis prevention strategies, hepatitis B virus (HBV) treatments, and hepatitis C virus (HCV) treatments.
ASHP Professional Certificates? Requirement
Once a learner has completed the Specialty Pharmacy Fundamentals and the Hepatitis track educational curriculum, they will have the opportunity to complete the track final exam. Once the learner successfully completes the track final exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the professional certificate.
Educational Activities
Hepatitis Overview
ACPE: 0204-0000-24-720-H01-P
Application-based
1.5 contact hours
Learning Objectives:
- Discuss the worldwide strain prevalence of hepatitis A, B, and C.
- Identify key facts regarding the transmission, symptoms, case numbers, and risk factors of hepatitis A, B, and C.
- Compare the disease duration and complications of hepatitis A, B, and C.
- Summarize prevention, testing, and treatment strategies of hepatitis A, B, and C.
- Explain the diagnostic tests that are used to determine if fibrosis is present and staging.
- Differentiate compensated from decompensated liver cirrhosis.
- Describe the natural history and progression of liver disease.
Hepatitis Prevention
ACPE: 0204-0000-24-721-H01-P
Application-based
1 contact hour
Learning Objectives:
- Discuss hepatitis A, B, and C prevention strategies.
- Compare hepatitis A and B recommendations for pediatrics and adults.
- Recommend appropriate hepatitis related post-exposure prophylaxis.
Hepatitis B Virus (HBV) Treatments
ACPE: 0204-0000-24-722-H01-P
Application-based
4.25 contact hours
Learning Objectives:
- Interpret hepatitis B virus (HBV) serologies.
- Categorize the level of infection and inflammation in chronic HBV.
- Compare the nomenclature for chronic HBV between American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL).
- Identify patients who meet appropriate criteria for HBV treatment.
- Select an appropriate drug therapy to treat chronic HBV.
- Construct a treatment plan and follow-up monitoring for chronic HBV.
- Select appropriate HBV antivirals for HIV or HCV co-infection treatment.
- Given a case, choose an appropriate therapy for a special population of HBV.
- Identify risk factors for HBV reactivation.
- Develop a plan for monitoring and treatment of HBV reactivation.
- Explain the consequences of HBV resistance and the importance in selecting appropriate drug therapy.
Hepatitis C Virus (HCV) Treatments
ACPE: 0204-0000-24-723-H01-P
Application-based
3.5 contact hours
Learning Objectives:
- Identify patient-specific factors that will impact hepatitis C (HCV) treatment selection.
- Develop a patient-specific HCV monitoring plan for baseline, on-treatment, and post-treatment.
- Identify significant drug-drug interactions with HCV direct acting antivirals.
- Develop an appropriate therapeutic plan for HCV treatment-naïve patients.
- Develop an appropriate therapeutic plan for HCV treatment-experienced patients based on prior treatment history.
- Design an appropriate HCV treatment plan for patients with the following comorbidities: HBV, HIV, transplant, decompensated cirrhosis.
- Develop an appropriate therapeutic plan for a pregnant or pediatric patient.
Faculty Information
Wiyanna K. Bruck, Pharm.D., BCPS, BCIDP, BCPPS
Clinical Coordinator
Infectious Diseases/Antimicrobial Stewardship Clinical Pharmacist
East Tennessee Children's Hospital
Knoxville, Tennessee
Anthony Dalpiaz, PharmD
Clinical Pharmacist Gastroenterology/Hepatology
University of Utah Health hospitals and Clinics
Assistant Professor (Adjunct), Department of Pharmacotherapy
University of Utah College of Pharmacy
Salt Lake City, Utah
Rebecca Hluhanich, PharmD, AAHIVP, BCPS
Senior Pharmacist, Internal Medicine
University of California Davis Health
Sacramento, California
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
- Rebecca Hluhanich: Gilead Sciences, stock
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
Methods and CE Requirements
Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP profile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
ASHP Professional Certificates? contains learning activities that are ACPE-accredited knowledge and application-based continuing education. This is not an ACPE Certificate Program. Upon successful completion of the activities, the learner will be able to download an ASHP Professional Certificate?.
System Technical Requirements
System requirements courses and learning activities are delivered via your web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating web sites. View the minimum technical and system requirements for learning activities.